Skip to content

Neil Mahapatra interview with Bloomberg

Bloomberg’s Sam Unsted sat down with Neil Mahapatra to discuss OCT’s $50 million investment drive

Oxford Cannabinoid Technologies Ltd is working on breaking cannabis extractions down to their constituent parts then investigating potential uses in immunology, oncology, neurology and pain relief.

The UK medical marijuana company backed by Snoop Dogg’s venture firm is targeting Big Pharma in its latest fundraising round and said drug makers getting involved in cannabis would help validate the burgeoning European industry.

Bloomberg’s Sam Unsted sat down with Neil Mahapatra to discuss OCT’s $50 million investment drive, the benefits of support from Big Pharma and the need for more research into the medical potential of cannabis.

Read more here